1. 383 EZETIMIBE FOR HYPERCHOLESTEROLEMIA IN PATIENTS AFTER HEART TRANSPLANT. (1st January 2005) Authors: Plesa, M.; Patel, J. K.; Marquez, A.; Nakashima, J.; Kobashigawa, J. A. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 513 EARLY DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY HAS POOR OUTCOME AFTER HEART TRANSPLANTATION. (1st January 2004) Authors: Nakashima, J.; Marquez, A.; Oeser, B. T.; Hamilton, M.; Kobashigawa, J. A. Journal: Journal of investigative medicine Issue: Volume 52(2004)Supplement 1 Page Start: S169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A preclinical evaluation of niraparib efficacy as monotherapy, maintenance and after olaparib treatment (PARP inhibitor after PARP inhibitor) in patient-derived ovarian xenograft tumor models. (February 2017) Authors: Mikule, K.; Wang, S.; Weroha, S.J.; Nakashima, J.; Wilcoxen, K. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Correlation of circumstellar SiO maser spot distribution with the stellar light curve. Issue 7 (July 2016) Authors: Oyadomari, M.; Imai, H.; Nagayama, T.; Oyama, T; Matsumoto, N; Nakashima, J.; Cho, S.-H. Journal: Journal of physics Issue: Volume 728:Issue 7(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-1537 Evaluation of an independent dose calculation software based on AAPM Task Group 219. (May 2022) Authors: Dias, J.; Avelino, S.; Peron, T.; Nakashima, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Regulation of oncogenic transcription and tumor growth in pediatric cancers by the CDK9 inhibitor KB-0742. (October 2022) Authors: Saffran, D.; Poon, E.; Ibanez, G.; Nakashima, J.; Naffar-Abu Amara, S.; Noe, C.; Hood, T.; Kumar, P.; DiMartino, J.; Dela Cruz, F.; Chesler, L.; Lin, C.Y. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The actin cytoskeleton is a suppressor of the endogenous skewing behaviour of Arabidopsis primary roots in microgravity. (16th August 2013) Authors: Nakashima, J.; Liao, F.; Sparks, J. A.; Tang, Y.; Blancaflor, E. B. Editors: Palme, K. Journal: Plant biology Issue: Volume 16:Number 1(2014:Jan.)supplement 1 Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗